KUALA LUMPUR, October 9 – AGAPE ATP Corporation (ATPC), a NASDAQ-listed company, has entered a strategic collaboration with FORMEDIC Technologies Sdn. Bhd. to introduce LEGA, an innovative electronic chest percussion device aimed at revolutionizing respiratory care. LEGA assists patients suffering from chronic respiratory conditions like COPD, pneumonia, and bronchiectasis by facilitating airway clearance and secretion management, providing much-needed relief for both hospital and home care patients.
This partnership aligns with the growing global demand for advanced respiratory solutions, with the market expected to reach USD 49.84 billion by 2031. The collaboration leverages FORMEDIC’s healthcare expertise and ATPC’s expanding wellness portfolio, offering a comprehensive approach to respiratory health. Prof. Dato’ Sri Dr. How Kok Choong, ATPC’s Founder and CEO, emphasized the partnership’s significance in addressing critical global health needs, while FORMEDIC’s Director, Ng Zim Guan, highlighted LEGA’s proven success in improving respiratory outcomes.
